p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats
- 15 January 1997
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 112 (1) , 5-10
- https://doi.org/10.1016/s0304-3835(96)04537-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Osteosarcoma and other tumors of boneCurrent Opinion in Oncology, 1994
- MDM2 gene amplification correlates with ring chromosomes in soft tissue tumorsGenes, Chromosomes and Cancer, 1994
- The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.Molecular and Cellular Biology, 1993
- Amplification of c‐myc oncogene and absence of c‐Ha‐ras point mutation in human bone sarcomaJournal of Orthopaedic Research, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of boneZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Amplification of Both c‐myc and c‐raf‐1 Oncogenes in a Human OsteosarcomaJapanese Journal of Cancer Research, 1989
- Integration and loss of a single ν‐Ki‐ras gene affects tumorigenic potential of human osteosarcoma cellsFEBS Letters, 1988